BACKGROUND: Routine and timely determination of total serum bilirubin (TSB) remains a challenge in many resource-limited countries with substantial burden of severe neonatal hyperbilirubinemia. Limited evidence exists on the potential usefulness of transcutaneousbilirubin (TcB) to identify infants who may require phototherapy based on possible treatment criteria in such settings.
OBJECTIVE: To compare the number of infants requiring phototherapy across different TSB criteria and determine the predictive performance of TcB under each criterion.
METHODS: Infants with paired TcB and TSB measurements in a maternity hospital in Lagos, Nigeria, were assessed for phototherapy based on TSB criteria by the American Academy of Pediatrics (AAP), National Institute for Health and Clinical Excellence (NICE) UK, and World Health Organization (WHO), and an absolute threshold of ≥12 mg/dL. The predictive performance of TcB across treatment criteria was evaluated with receiver operating curve analysis.
The number of infants requiring phototherapy varies significantly across treatment criteria. TcB may be useful in identifying infants who do not require phototherapy, but may also identify a high proportion of false positives that is burdensome in resource-limitedsettings.
Facebook : PORT SAID EIGHTH NEONATOLOGY CONFERENCE 2017 SHARING STAFF: Prof Abla El Aalfy (Executive director of our dream project ) Prof Ahmed El Lawah (Alazhar univ) Prof Alaa Sobeih (Cairo univ) Prof Ahmed Amr Abbassy (Alexandria univ) Prof Atef Donia (Alazhar univ) Prof David Clark (USA) Dr. Elsayed Khalaf (Port Fouad hosp,…